{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:10:37Z","timestamp":1767474637759,"version":"3.48.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Women Living with HIV (WLHIV) are at increased risk of persistent high-risk Human Papillomavirus (HR-HPV) infections and cervical cancer. However, data on HPV genotype distribution and cervical cytologic abnormalities remain limited in North Africa, particularly among women receiving effective antiretroviral therapy (ART).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the frequency of cytologic abnormalities in WLHIV in S\u00e9tif, Algeria, identify HR-HPV genotypes, and evaluate associated immunovirological factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted from January to December 2024 at the HIV\/STI\/AIDS Reference Center in S\u00e9tif. WLHIV aged\u2009\u2265\u200918 years who provided informed consent were included. Each participant underwent a gynecological examination, cervical cytology (Pap smear), HR-HPV genotyping by molecular biology, and immunovirological assessment (CD4 T-cell count, HIV viral load). Colposcopy and biopsy were performed when indicated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 115 enrolled participants, 100 smears were interpretable. Cytologic abnormalities : Atypical Squamous Cells of Undetermined Significance (ASC-US), Low-Grade\/High-Grade Squamous Intraepithelial Lesions LSIL, HSIL) were found in 28% of WLHIV. HR-HPV infection was detected in 32% of participants, mainly genotypes HPV52, HPV16, and HPV18. A significant association was observed between HR-HPV positivity and high-grade lesions (HSIL) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.018; OR\u2009=\u20099.57, 95% CI: 1.02\u201389.48).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>WLHIV in Algeria show a high prevalence of HPV-related cytologic abnormalities, even with adequate immune status and viral suppression. These findings emphasize the importance of regular cervical screening and support current global recommendations for comprehensive prevention strategies, including HPV testing and vaccination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13027-025-00717-4","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:05:07Z","timestamp":1764331507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytologic and histologic cervical lesions and oncogenic HPV in women living with HIV (WLHIV) despite viral suppression: first evidence from Algeria"],"prefix":"10.1186","volume":"21","author":[{"given":"Mounira","family":"Rais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amel","family":"Ouyahia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriem","family":"Abdoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Taleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriem","family":"Guechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noudjoud","family":"Amoura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"717_CR1","first-page":"22","volume":"23","author":"M Bammo","year":"2015","unstructured":"Bammo M, Diouss\u00e9 P, Thiam M, Diop MM, Berthe A, Faye FA, et al. Les aspects des Frottis cervico-vaginaux Chez Les femmes vivants avec Le VIH suivies \u00e0 Thi\u00e8s\/S\u00e9n\u00e9gal et association avec Le degr\u00e9 d\u2019immunod\u00e9pression. Pan Afr Med J. 2015;23:22.","journal-title":"Pan Afr Med J"},{"issue":"2","key":"717_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1297-9589(01)00282-X","volume":"30","author":"D Riethmuller","year":"2002","unstructured":"Riethmuller D, Schaal JP, Mougin C. \u00c9pid\u00e9miologie et histoire naturelle de l\u2019infection g\u00e9nitale \u00e0 papillomavirus Humain. Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9. 2002;30(2):139\u201346.","journal-title":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9"},{"issue":"5","key":"717_CR3","first-page":"399","volume":"90","author":"P Pautier","year":"2003","unstructured":"Pautier P, Morice P, de Crevoisier R. HIV and uterine cervical cancer. Bull Cancer. 2003;90(5):399\u2013404.","journal-title":"Bull Cancer"},{"key":"717_CR4","unstructured":"N\u2019Guessan E, Anongba S, Guie S, et al. Anomalies cervicales chez la femme vivant avec le VIH : \u00e9tude cas\u2013t\u00e9moins \u00e0 propos de 153 frottis cervico-vaginaux r\u00e9alis\u00e9s au CHU de Treichville du 1er octobre 2003 au 31 mars 2004. La Seyne-sur-Mer (France): API DPM; 2007. 7 p"},{"issue":"5","key":"717_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajog.2014.12.003","volume":"212","author":"LS Massad","year":"2015","unstructured":"Massad LS, Xie X, D\u2019Souza G, Darragh TM, Minkoff H, Wright R, et al. Incidence of cervical precancers among HIV-seropositive women. Am J Obstet Gynecol. 2015;212(5):10.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"717_CR6","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/ijc.29913","volume":"138","author":"GM Clifford","year":"2016","unstructured":"Clifford GM, Franceschi S, Keiser O, Schoni-Affolter F, Lise M, Dehler S, et al. Immunodeficiency and the risk of cervical intraepithelial neoplasia 2\/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study. Int J Cancer. 2016;138(7):1732\u201340.","journal-title":"Int J Cancer"},{"issue":"3","key":"717_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ajog.2015.09.086","volume":"214","author":"LS Massad","year":"2016","unstructured":"Massad LS, Xie X, Burk RD, D\u2019Souza G, Darragh TM, Minkoff H, et al. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women. Am J Obstet Gynecol. 2016;214(3):14.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"717_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/jama.2012.5664","volume":"308","author":"MJ Keller","year":"2012","unstructured":"Keller MJ, Burk RD, Xie X, Anastos K, Massad LS, Minkoff H, et al. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection. JAMA. 2012;308(4):362\u20139.","journal-title":"JAMA"},{"issue":"10","key":"717_CR9","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/cid\/civ569","volume":"61","author":"MJ Keller","year":"2015","unstructured":"Keller MJ, Burk RD, Massad LS, Eltoum IE, Hessol NA, Castle PE, et al. Cervical precancer risk in HIV-Infected women who test positive for oncogenic human papillomavirus despite a normal pap test. Clin Infect Dis. 2015;61(10):1573\u201381.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"717_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.gyobfe.2010.08.031","volume":"38","author":"B Koffi","year":"2010","unstructured":"Koffi B, Serdouma E, Mbolissa-Ngu\u00e9r\u00e9koudou W, Ngadjou-Kouchou-Fondjo M, Pengoussou-Gbatoumba V, S\u00e9pou A, et al. Dysplasies cervicales Chez Les femmes s\u00e9ropositives pour Le VIH En zone de Forte pr\u00e9valence de l\u2019infection. Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9. 2010;38(10):576\u201380.","journal-title":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9"},{"issue":"5","key":"717_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.gyobfe.2008.02.007","volume":"36","author":"A Berr\u00e9bi","year":"2008","unstructured":"Berr\u00e9bi A, Badiou W, Duclusaud A. Fr\u00e9quence, persistance et r\u00e9cidive des l\u00e9sions \u00e0 HPV du col ut\u00e9rin Chez Les patientes s\u00e9ropositives pour Le VIH. Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9. 2008;36(5):521\u20134.","journal-title":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9"},{"key":"717_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/978-2-287-72066-6_42","volume-title":"Trait\u00e9 des infections et pathologies g\u00e9nitales \u00e0 papillomavirus","author":"I Heard","year":"2007","unstructured":"Heard I. Pathologie g\u00e9nitale li\u00e9e \u00e0 l\u2019infection par Les HPV Chez Les femmes s\u00e9ropositives pour Le VIH. In: Monsonego J, editor. Trait\u00e9 des infections et pathologies g\u00e9nitales \u00e0 papillomavirus. Paris: Springer Paris; 2007. pp. 347\u201359."},{"key":"717_CR13","doi-asserted-by":"crossref","unstructured":"Moscicki A-B, Schiffman M, Burchell A, Albero G, Giuliano AR, Goodman MT, et al. Updating the natural history of human papillomavirus and anogenital cancers. Vaccine. 2012;30, Supplement 5:F24-F33.","DOI":"10.1016\/j.vaccine.2012.05.089"},{"key":"717_CR14","doi-asserted-by":"publisher","unstructured":"Clark RA, Kendall MA, Robinson WR. Progression of cervical disease among adolescents infected with HIV with low-grade squamous intraepithelial lesions: J Acquir Immune Defic Syndr. 2002;31(5):543-5. https:\/\/doi.org\/10.1097\/00126334-200212150-00014.; 2002.","DOI":"10.1097\/00126334-200212150-00014"},{"issue":"4","key":"717_CR15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ijc.25396","volume":"128","author":"N Li","year":"2011","unstructured":"Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128(4):927\u201335.","journal-title":"Int J Cancer"},{"key":"717_CR16","doi-asserted-by":"crossref","unstructured":"Sando Z. Prevalence and geographical distribution of precancerous lesions of the uterine cervix in Cameroon. J Cytol Histol. 2013;04.","DOI":"10.4172\/2157-7099.1000183"},{"issue":"3","key":"717_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canep.2011.10.003","volume":"36","author":"J Atashili","year":"2012","unstructured":"Atashili J, Adimora AA, Ndumbe PM, Ikomey GM, Rinas AC, Myers E, et al. High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in cameroon: is targeted screening feasible? Cancer Epidemiol. 2012;36(3):263\u20139. Epub 2011\/11\/01.","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"717_CR18","first-page":"433","volume":"21","author":"C Firnhaber","year":"2010","unstructured":"Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, Sanne IM, et al. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control. 2010;21(3):433\u201343.","journal-title":"Cancer Causes Control"},{"issue":"32","key":"717_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0968-8080(08)32415-X","volume":"16","author":"RI Anorlu","year":"2008","unstructured":"Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008;16(32):41\u20139.","journal-title":"Reprod Health Matters"},{"key":"717_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1750-9378-4-9","volume":"4","author":"K Martin Luther","year":"2009","unstructured":"Martin Luther K, Malieugoue L, Djiepgang C, Wankam M, Moune A, Ngane RA. Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy. Infect Agent Cancer. 2009;4:9.","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"717_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3855\/jidc.9711","volume":"12","author":"A Ouladlahsen","year":"2018","unstructured":"Ouladlahsen A, Fayssel N, Bensghir R, Baba H, Lamdini H, Sodqi M, et al. The human papillomavirus among women living with human immunodeficiency virus in morocco: A prospective cross-sectional study. J Infect Dev Ctries. 2018;12(6):477\u201384.","journal-title":"J Infect Dev Ctries"},{"key":"717_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13027-015-0040-y","volume":"10","author":"E Belglaiaa","year":"2015","unstructured":"Belglaiaa E, Elannaz H, Mouaouya B, Aksim M, Mercier M, Pr\u00e9tet J-L, et al. Human papillomavirus genotypes among women with or without HIV infection: an epidemiological study of Moroccan women from the Souss area. Infect Agent Cancer. 2015;10:44.","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"717_CR23","first-page":"429","volume":"23","author":"AM Mroueh","year":"2002","unstructured":"Mroueh AM, Seoud MA, Kaspar HG, Zalloua PA. Prevalence of genital human papillomavirus among Lebanese women. Eur J Gynaecol Oncol. 2002;23(5):429\u201332.","journal-title":"Eur J Gynaecol Oncol"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00717-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-025-00717-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-025-00717-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:04:58Z","timestamp":1767474298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13027-025-00717-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["717"],"URL":"https:\/\/doi.org\/10.1186\/s13027-025-00717-4","relation":{},"ISSN":["1750-9378"],"issn-type":[{"type":"electronic","value":"1750-9378"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the Declaration of Helsinki and was approved by the Ethics Committee of the University Hospital Center of S\u00e9tif, Algeria. Due to sociocultural sensitivities related to HIV, the committee authorized verbal informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}